This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

CROMSOURCE Announces Industry Leading Timeline And Budget Guarantee

VERONA, Italy, February 27, 2013 /PRNewswire/ --

CROMSOURCE, an international full service contract research organization (CRO), today announced a unique alternative to the routine delays and budget escalations which characterise the delivery of clinical trials. CROMSOURCE now offers clients the industry's only End-to-End Guarantee. Within this pledge CROMSOURCE assures clients that their projects will be delivered according to the contracted timelines and to the price written on the contract.

'For nearly 20 years CROMSOURCE has been delivering high quality projects to our clients on time and on budget, contrasting markedly with the clinical research environment in general where delays and cost escalations are seen as almost inevitable ', noted Oriana Zerbini, CEO of CROMSOURCE. 'The announcement of our End-to-End Guarantee today builds on this history by providing CROMSOURCE clients a written assurance that their projects will be completed on time and to the original contract price. Furthermore, as an early adopter of ISO certification our clients know that CROMSOURCE never compromise on quality.'

'Our broad range of integrated services, coupled with our operational excellence and absolute client focus means that we can provide this revolutionary guarantee', said Antoinette Torres Frankum, Head of US Operations. 'When we describe our success rate over nearly 20 years in hitting timelines whilst maintaining the original and highly competitive contract price most potential clients are extremely surprised. We have therefore formalized our commitment by announcing our End-to-End Guarantee, and hope this encourages sponsors to reject the assumption that the milestones and budget written into a CRO contract must be somehow flexible.'

Kerry Dyson, Head of UK Operations, explained 'The CROMSOURCE philosophy is to act as an expert addition to each client's team. We leverage our expertise and comprehensive Feasibility Plus [ TM ] process to propose the optimal approach to each project. Once this approach is agreed we commit to deliver it to the highest quality, on time and on budget. Advise Agree Deliver: Guaranteed.'

About CROMSOURCE: Founded in 1994, CROMSOURCE is a high quality ISO-certified international provider of outsourced services to the pharmaceutical, biotechnology and medical device industries, specialized in clinical development and staffing solutions. Readers can visit our new website to learn more about our services and guarantees.

Contact: Margherita Mosconi CROMSOURCE Phone: +39-(0)45-8222811 Fax: +39-(0)45-8222812


Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.26 -0.77%
FB $101.50 2.00%
GOOG $684.03 0.87%
TSLA $163.06 10.00%
YHOO $27.10 1.00%


Chart of I:DJI
DOW 15,914.74 -99.64 -0.62%
S&P 500 1,851.86 -0.35 -0.02%
NASDAQ 4,283.5920 +14.8290 0.35%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs